FDA approves Moderna's mRNA seasonal flu vaccine

Source ABC Local
Original Load Date Aug. 6, 2026, 5 a.m.
Last Updated Aug. 6, 2026, 5 a.m.
Original URL https://abc7chicago.com/story/fda-approves-modernas-mrna-seasonal-flu-vaccine/19634596/

Article Preview

The Food and Drug Administration approved Moderna's mRNA seasonal flu vaccine on Wednesday. The vaccine, mFLUSIVA, is expected to be available for people 50 and older for the 2026-2027 respiratory illness season. "Flu remains a significant public health challenge, and mFLUSIVA provides an importan...